Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erwan Bezard

Showing results (171-180 of 298) with videos related to

Pageof 30
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 6, 2003
Enriched environment confers resistance to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and cocaine: involvement of dopamine transporter and trophic factorsErwan Bezard, Sandra Dovero, David Belin, et al.
The Lancet. Neurology|November 14, 2009
Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disordersValerie Voon, Pierre-Olivier Fernagut, Jeff Wickens, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 2010
Inhibition of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) signaling in the striatum reverts motor symptoms associated with L-dopa-induced dyskinesiaStefania Fasano, Erwan Bezard, Angela D'Antoni, et al.
Neurobiology of Disease|May 11, 2010
A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeysDaniella Rylander, Hanna Iderberg, Qin Li, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 16, 2020
Nilotinib Fails to Prevent Synucleinopathy and Cell Loss in a Mouse Model of Multiple System AtrophyMiguel Lopez-Cuina, Paul A Guerin, Marie-Hélène Canron, et al.
Acta Neuropathologica Communications|January 11, 2017
Endosulfine-alpha inhibits membrane-induced α-synuclein aggregation and protects against α-synuclein neurotoxicityDaniel Ysselstein, Benjamin Dehay, Isabel M Costantino, et al.
The European Journal of Neuroscience|July 21, 2005
Levodopa-induced dyskinesia in MPTP-treated macaques is not dependent on the extent and pattern of nigrostrial lesioningCéline Guigoni, Sandra Dovero, Incarnation Aubert, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 25, 2005
Involvement of sensorimotor, limbic, and associative basal ganglia domains in L-3,4-dihydroxyphenylalanine-induced dyskinesiaCéline Guigoni, Qin Li, Incarnation Aubert, et al.
Neurobiology of Disease|June 25, 2018
The expression of cannabinoid type 1 receptor and 2-arachidonoyl glycerol synthesizing/degrading enzymes is altered in basal ganglia during the active phase of levodopa-induced dyskinesiaEstefania Rojo-Bustamante, Miguel Angel Abellanas, Pedro Clavero, et al.
Biological Psychiatry|September 5, 2006
Enhanced preproenkephalin-B-derived opioid transmission in striatum and subthalamic nucleus converges upon globus pallidus internalis in L-3,4-dihydroxyphenylalanine-induced dyskinesiaIncarnation Aubert, Céline Guigoni, Qin Li, et al.
Pageof 30

Showing results (171-180 of 298) with videos related to

Sort By:
Pageof 30
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 6, 2003
Enriched environment confers resistance to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and cocaine: involvement of dopamine transporter and trophic factorsErwan Bezard, Sandra Dovero, David Belin, et al.
The Lancet. Neurology|November 14, 2009
Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disordersValerie Voon, Pierre-Olivier Fernagut, Jeff Wickens, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 2010
Inhibition of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) signaling in the striatum reverts motor symptoms associated with L-dopa-induced dyskinesiaStefania Fasano, Erwan Bezard, Angela D'Antoni, et al.
Neurobiology of Disease|May 11, 2010
A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeysDaniella Rylander, Hanna Iderberg, Qin Li, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 16, 2020
Nilotinib Fails to Prevent Synucleinopathy and Cell Loss in a Mouse Model of Multiple System AtrophyMiguel Lopez-Cuina, Paul A Guerin, Marie-Hélène Canron, et al.
Acta Neuropathologica Communications|January 11, 2017
Endosulfine-alpha inhibits membrane-induced α-synuclein aggregation and protects against α-synuclein neurotoxicityDaniel Ysselstein, Benjamin Dehay, Isabel M Costantino, et al.
The European Journal of Neuroscience|July 21, 2005
Levodopa-induced dyskinesia in MPTP-treated macaques is not dependent on the extent and pattern of nigrostrial lesioningCéline Guigoni, Sandra Dovero, Incarnation Aubert, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 25, 2005
Involvement of sensorimotor, limbic, and associative basal ganglia domains in L-3,4-dihydroxyphenylalanine-induced dyskinesiaCéline Guigoni, Qin Li, Incarnation Aubert, et al.
Neurobiology of Disease|June 25, 2018
The expression of cannabinoid type 1 receptor and 2-arachidonoyl glycerol synthesizing/degrading enzymes is altered in basal ganglia during the active phase of levodopa-induced dyskinesiaEstefania Rojo-Bustamante, Miguel Angel Abellanas, Pedro Clavero, et al.
Biological Psychiatry|September 5, 2006
Enhanced preproenkephalin-B-derived opioid transmission in striatum and subthalamic nucleus converges upon globus pallidus internalis in L-3,4-dihydroxyphenylalanine-induced dyskinesiaIncarnation Aubert, Céline Guigoni, Qin Li, et al.
Pageof 30